Report Code: A14426 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Butylscopolamine Market
Request Now !Butylscopolamine is an anticholinergic and antimuscarinic medication, mostly in tablet form, which is used to treat disorders related to irritable bowel syndrome such as stomach cramps, abdominal pians, renal colic, or spasmodic discomforts, including esophageal spasm and bladder spasm. Along with the mentioned pains and discomforts, this drug helps to improve respiratory secretions. This is not exactly a pain medication, as it does not directly act on reducing the pain but helps to prevent the painful cramps. It acts by relaxing the muscle of the bowel or other target area.
Impact of COVID-19 Pandemic on Butylscopolamine Market (Pre and Post Analysis)
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the butylscopolamine market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2019, European Bioinformatics Institute, an intergovernmental organization, launched butylscopolamine bromide (CHEBI:32123) to provide relief to painful stomach cramps.Â
Key Benefits of the Report
Questions answered in the butylscopolamine report
Butylscopolamine Market Report Highlights
Aspects | Details |
---|---|
By Therapy Type |
|
By Condition |
|
By Application |
|
By Region |
|
Key Market Players | Syntree, Alkaloida Corp, Shandong Yijian Pharmaceutical Sigma-Aldrich, Linnea, AvaChem Scientific, Guangdong Zhongsheng Pharmaceutical, XI AN TIANXINGJIAN PHARMCHEM, Parchem, Wolves RandD chemical, Combi-Blocks, OXCHEM CORPORATION, Sandoz (Novartis), Wanbangde Pharmaceutical Group, Jiangsu Ange Pharmaceutical, Boehringer Ingelheim, Chengdu First Pharmaceutical |
Start reading.
This Report and over 68,113+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers